123 related articles for article (PubMed ID: 38615405)
1. Data-driven subtypes of mixed semantic-logopenic primary progressive aphasia: Linguistic features, biomarker profiles and brain metabolic patterns.
Mazzeo S; Morinelli C; Polito C; Giacomucci G; Moschini V; Ingannato A; Balestrini J; Frigerio D; Emiliani F; Galdo G; Crucitti C; Piazzesi D; Bagnoli S; Padiglioni S; Berti V; Sorbi S; Nacmias B; Bessi V
J Neurol Sci; 2024 May; 460():122998. PubMed ID: 38615405
[TBL] [Abstract][Full Text] [Related]
2. Linguistic profiles, brain metabolic patterns and rates of amyloid-β biomarker positivity in patients with mixed primary progressive aphasia.
Mazzeo S; Polito C; Padiglioni S; Berti V; Bagnoli S; Lombardi G; Piaceri I; Carraro M; De Cristofaro MT; Passeri A; Ferrari C; Nacmias B; Sorbi S; Bessi V
Neurobiol Aging; 2020 Dec; 96():155-164. PubMed ID: 33010672
[TBL] [Abstract][Full Text] [Related]
3. The ScreeLing: Detecting Semantic, Phonological, and Syntactic Deficits in the Clinical Subtypes of Frontotemporal and Alzheimer's Dementia.
Jiskoot LC; Poos JM; van Boven K; de Boer L; Giannini LAA; Satoer DD; Visch-Brink EG; van Hemmen J; Franzen S; Pijnenburg YAL; van den Berg E; Seelaar H
Assessment; 2023 Dec; 30(8):2545-2559. PubMed ID: 36799220
[TBL] [Abstract][Full Text] [Related]
4. The Role of Single-Subject Brain Metabolic Patterns in the Early Differential Diagnosis of Primary Progressive Aphasias and in Prediction of Progression to Dementia.
Cerami C; Dodich A; Greco L; Iannaccone S; Magnani G; Marcone A; Pelagallo E; Santangelo R; Cappa SF; Perani D
J Alzheimers Dis; 2017; 55(1):183-197. PubMed ID: 27662315
[TBL] [Abstract][Full Text] [Related]
5. Varying Degrees of Temporoparietal Hypometabolism on FDG-PET Reveal Amyloid-Positive Logopenic Primary Progressive Aphasia is not a Homogeneous Clinical Entity.
Krishnan K; Machulda MM; Whitwell JL; Butts AM; Duffy JR; Strand EA; Senjem ML; Spychalla AJ; Jack CR; Lowe VJ; Josephs KA
J Alzheimers Dis; 2017; 55(3):1019-1029. PubMed ID: 27802232
[TBL] [Abstract][Full Text] [Related]
6. Abeta amyloid and glucose metabolism in three variants of primary progressive aphasia.
Rabinovici GD; Jagust WJ; Furst AJ; Ogar JM; Racine CA; Mormino EC; O'Neil JP; Lal RA; Dronkers NF; Miller BL; Gorno-Tempini ML
Ann Neurol; 2008 Oct; 64(4):388-401. PubMed ID: 18991338
[TBL] [Abstract][Full Text] [Related]
7. High Frequency of Crossed Aphasia in Dextral in an Italian Cohort of Patients with Logopenic Primary Progressive Aphasia.
Ferrari C; Polito C; Berti V; Lombardi G; Lucidi G; Bessi V; Bagnoli S; Piaceri I; Nacmias B; Sorbi S
J Alzheimers Dis; 2019; 72(4):1089-1096. PubMed ID: 31683481
[TBL] [Abstract][Full Text] [Related]
8. Heterogeneous Language Profiles in Patients with Primary Progressive Aphasia due to Alzheimer's Disease.
Louwersheimer E; Keulen MA; Steenwijk MD; Wattjes MP; Jiskoot LC; Vrenken H; Teunissen CE; van Berckel BN; van der Flier WM; Scheltens P; van Swieten JC; Pijnenburg YA
J Alzheimers Dis; 2016; 51(2):581-90. PubMed ID: 26890751
[TBL] [Abstract][Full Text] [Related]
9. Cerebrospinal Fluid Biomarkers as a Diagnostic Tool of the Underlying Pathology of Primary Progressive Aphasia.
Paraskevas GP; Kasselimis D; Kourtidou E; Constantinides V; Bougea A; Potagas C; Evdokimidis I; Kapaki E
J Alzheimers Dis; 2017; 55(4):1453-1461. PubMed ID: 27858708
[TBL] [Abstract][Full Text] [Related]
10. Heterogeneity and overlap in the continuum of linguistic profile of logopenic and semantic variants of primary progressive aphasia: a Profile Analysis based on Multidimensional Scaling study.
Santi GC; Conca F; Esposito V; Polito C; Caminiti SP; Boccalini C; Morinelli C; Berti V; Mazzeo S; Bessi V; Marcone A; Iannaccone S; Kim SK; Sorbi S; Perani D; Cappa SF; Catricalà E
Alzheimers Res Ther; 2024 Mar; 16(1):49. PubMed ID: 38448894
[TBL] [Abstract][Full Text] [Related]
11. Differential chemokine alteration in the variants of primary progressive aphasia-a role for neuroinflammation.
Sogorb-Esteve A; Swift IJ; Woollacott IOC; Warren JD; Zetterberg H; Rohrer JD
J Neuroinflammation; 2021 Oct; 18(1):224. PubMed ID: 34602080
[TBL] [Abstract][Full Text] [Related]
12. Amyloid pet in primary progressive aphasia: case series and systematic review of the literature.
Villarejo-Galende A; Llamas-Velasco S; Gómez-Grande A; Puertas-Martín V; Contador I; Sarandeses P; González-Sánchez M; Trincado R; Pilkington P; Ruiz-Solis S; Pérez-Martínez DA; Herrero-San Martín A
J Neurol; 2017 Jan; 264(1):121-130. PubMed ID: 27815682
[TBL] [Abstract][Full Text] [Related]
13. CSF levels of Aβ1-38/Aβ1-40/Aβ1-42 and (11)C PiB-PET studies in three clinical variants of primary progressive aphasia and Alzheimer's disease.
Ikeda M; Tashiro Y; Takai E; Kurose S; Fugami N; Tsuda K; Arisaka Y; Kodaira S; Fujita Y; Makioka K; Mizuno Y; Shimada H; Harigaya Y; Takatama M; Amari M; Yamazaki T; Yamaguchi H; Higuchi T; Okamoto K; Tsushima Y; Ikeda Y
Amyloid; 2014 Dec; 21(4):238-45. PubMed ID: 25139672
[TBL] [Abstract][Full Text] [Related]
14. Role of Cerebrospinal Fluid Biomarkers and (18)F-florbetapir PET Imaging in the Diagnosis of Primary Progressive Aphasia: A Retrospective Analysis.
Perini G; Cotta Ramusino M; Sinforiani E; Franciotta D; Trifirò G; Ceroni M; Costa A
Alzheimer Dis Assoc Disord; 2019; 33(3):282-284. PubMed ID: 30640253
[TBL] [Abstract][Full Text] [Related]
15. Progranulin-associated PiB-negative logopenic primary progressive aphasia.
Josephs KA; Duffy JR; Strand EA; Machulda MM; Vemuri P; Senjem ML; Perkerson RB; Baker MC; Lowe V; Jack CR; Rademakers R; Whitwell JL
J Neurol; 2014 Mar; 261(3):604-14. PubMed ID: 24449064
[TBL] [Abstract][Full Text] [Related]
16. Clinical Characteristic in Primary Progressive Aphasia in Relation to Alzheimer's Disease Biomarkers.
Kang SH; Cho H; Shin J; Kim HR; Noh Y; Kim EJ; Lyoo CH; Jang H; Kim HJ; Koh SB; Na DL; Suh MK; Seo SW
J Alzheimers Dis; 2021; 84(2):633-645. PubMed ID: 34569949
[TBL] [Abstract][Full Text] [Related]
17. Cerebrospinal fluid biomarkers can play a pivotal role in the diagnostic work up of primary progressive aphasia.
Santangelo R; Coppi E; Ferrari L; Bernasconi MP; Pinto P; Passerini G; Comi G; Magnani G
J Alzheimers Dis; 2015; 43(4):1429-40. PubMed ID: 25201781
[TBL] [Abstract][Full Text] [Related]
18. Fluorodeoxyglucose F18 positron emission tomography in progressive apraxia of speech and primary progressive aphasia variants.
Josephs KA; Duffy JR; Fossett TR; Strand EA; Claassen DO; Whitwell JL; Peller PJ
Arch Neurol; 2010 May; 67(5):596-605. PubMed ID: 20457960
[TBL] [Abstract][Full Text] [Related]
19. Clinicoradiological and neuropathological evaluation of primary progressive aphasia.
Shir D; Corriveau-Lecavalier N; Bermudez Noguera C; Barnard L; Pham NTT; Botha H; Duffy JR; Clark HM; Utianski RL; Knopman DS; Petersen RC; Boeve BF; Murray ME; Nguyen AT; Reichard RR; Dickson DW; Day GS; Kremers WK; Graff-Radford NR; Jones DT; Machulda MM; Fields JA; Whitwell JL; Josephs KA; Graff-Radford J
J Neurol Neurosurg Psychiatry; 2024 Mar; ():. PubMed ID: 38514176
[TBL] [Abstract][Full Text] [Related]
20. FDG-PET and CSF biomarker accuracy in prediction of conversion to different dementias in a large multicentre MCI cohort.
Caminiti SP; Ballarini T; Sala A; Cerami C; Presotto L; Santangelo R; Fallanca F; Vanoli EG; Gianolli L; Iannaccone S; Magnani G; Perani D;
Neuroimage Clin; 2018; 18():167-177. PubMed ID: 29387532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
